Diabetes Mellitus Stocks List

Diabetes Mellitus Stocks Recent News

Date Stock Title
Nov 16 DXCM What Moved Markets This Week
Nov 15 DXCM Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says
Nov 15 HALO Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer
Nov 15 HALO Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
Nov 15 DXCM DexCom, Inc. (DXCM): Among 12 High Growth Large Cap Stocks to Buy Now
Nov 15 GPCR Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
Nov 15 HALO Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
Nov 15 HALO Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
Nov 15 HALO Halozyme bids for Evotec; BeiGene gets a new name
Nov 15 RSLS ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript
Nov 14 HALO Germany’s Evotec Gets Takeover Interest From Halozyme
Nov 14 HALO Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
Nov 14 RSLS ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
Nov 14 DXCM Tiger Global's top Q3 trades include DexCom exit, new stake in Sherwin-Williams
Nov 14 HALO Evotec jumps as Halozyme confirms takeover interest (updated)
Nov 14 DXCM Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
Nov 14 RSLS Earnings Scheduled For November 14, 2024
Nov 13 GPCR Structure Therapeutics reports Q3 results
Nov 13 GPCR Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
Nov 13 GPCR Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
Diabetes Mellitus

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags